Skip to main content

Pharma

By Adam Ang | 04:02 am | July 25, 2023
It signed a distribution deal with UE LifeSciences to scale the access to iBreastExam in primary care clinics. 
By Jessica Hagen | 01:30 pm | July 13, 2023
The round brings the company's total raise to $93 million.
By HIMSS TV | 07:00 am | July 13, 2023
Naomi Fried, founder and CEO of PharmStars, discusses the 13 startups from its spring cohort and its call for applications for its fall 2023 cohort, Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.
By Jessica Hagen | 02:08 pm | July 12, 2023
The CVS Health company's members will have access to GoodRx's generic drug prices through the new program, Caremark Cost Saver.
By Jessica Hagen | 06:40 pm | June 28, 2023
Posterity Health users will have access to medications through MCCPDC that help treat infertility, sexual dysfunction and low testosterone.
By Jessica Hagen | 08:18 pm | June 02, 2023
In a statement to MobiHealthNews, the cofounder of Mark Cuban Cost Plus Drug Company expressed excitement over the deal to offer the discounted Humira alternative.
By Jessica Hagen | 01:00 pm | June 02, 2023
The partners will develop a database for academics and biopharma researchers to acquire insights to help advance cancer-focused research.
HIMSS23
By HIMSS TV | 01:00 pm | May 30, 2023
Dr. Colin Banas, chief medical officer at DrFirst, discusses how his company uses AI to automate tasks such as processing prescription refills, which prevents medication errors and reduces clinicians' administrative burden.
By Jessica Hagen | 01:58 pm | May 24, 2023
MJFF will use H1's AI-enabled platform to evaluate treatment approaches and improve clinical trial access for patients with Parkinson's from marginalized communities.
HIMSS23
By HIMSS TV | 01:00 pm | May 02, 2023
Anna Dover, director of product management at First Databank, discusses First Databank's medication decision support technology, which helps keep clinicians informed about prescription drug information without overwhelming them.